B.Riley FBR Reaffirms Their Buy Rating on Joint (JYNT)

By Jason Carr

B.Riley FBR analyst Jeff Van Sinderen reiterated a Buy rating on Joint (JYNTResearch Report) today and set a price target of $26.00. The company’s shares closed last Monday at $15.04.

According to TipRanks.com, Sinderen is a 1-star analyst with an average return of -0.6% and a 44.7% success rate. Sinderen covers the Consumer Goods sector, focusing on stocks such as Universal Electronics, Iteris, and Verso.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Joint with a $26.00 average price target.

See today’s analyst top recommended stocks >>

Joint’s market cap is currently $208.5M and has a P/E ratio of 75.05. The company has a Price to Book ratio of 54.88.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

The Joint Corp. (United States) engages in the development, ownership, operation, support and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment comprises of the operating activities of the company owned or managed clinics.